RP

Rachana Patel

Active Director Director DIN 07504737
DIN 07504737 First appointment Jun 2016 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value •••• Premium profile

About Rachana Patel

Data last updated:

Rachana Patel is a Director at Trio Biotech Private Limited (since 2016). The company operates in E-Commerce. Trio Biotech Private Limited reported revenue of ₹7.52 Cr (FY 2025).

DIN 07504737
Primary Designation Director
Industry E-Commerce
First Appointment 13 Jun 2016
Oldest Company Age 10 yrs
Largest company Trio Biotech Private Limited · ₹7.52 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trio Biotech Private Limited U52512JH2016PTC008867
Director13 Jun 20162016₹7.52 Cr (FY 2025)Active

Board colleagues of Rachana Patel

NameDINCompanyDesignation
Shiv Shah Awatar07453614Trio Biotech Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Trio Biotech Private Limited
Premium access

Shareholding and investment profile for Rachana Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rachana Patel

Rachana Patel currently holds 1 directorship: Trio Biotech Private Limited (Director, since 13 Jun 2016, revenue ₹7.52 Cr (FY 2025)).

Rachana Patel was first appointed on 13 Jun 2016 as Director at Trio Biotech Private Limited.

The current boards of Rachana Patel's companies include Shiv Shah Awatar (Trio Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available